To confirm the role of VEGFA co-phagocytosis via BsAb-induced ADCP (Figures 3 and 5) in improving antitumor responses to the BsAbs leading to a survival benefit (Figures 4 and 6), we examined the extent to which inhibition of ADCP affected tumor responses to the antibody treatments. The gene discussed is VEGFA; the disease is neoplasm.